Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa.
Mpofu R, Kawuma AN, Wasmann RE, Akpomiemie G, Chandiwana N, Sokhela SM, Moorhouse M, Venter WDF, Denti P, Wiesner L, Post FA, Haas DW, Maartens G, Sinxadi P.
Mpofu R, et al. Among authors: wasmann re.
Br J Clin Pharmacol. 2024 May;90(5):1247-1257. doi: 10.1111/bcp.16009. Epub 2024 Feb 8.
Br J Clin Pharmacol. 2024.
PMID: 38332460
Clinical Trial.